Rowland & CO Investment Counsel Amgen Inc Transaction History
Rowland & CO Investment Counsel
- $486 Million
- Q3 2024
A detailed history of Rowland & CO Investment Counsel transactions in Amgen Inc stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 18,115 shares of AMGN stock, worth $5.83 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
18,115
Previous 18,405
1.58%
Holding current value
$5.83 Million
Previous $5.75 Million
1.5%
% of portfolio
1.2%
Previous 1.26%
Shares
29 transactions
Others Institutions Holding AMGN
# of Institutions
3,085Shares Held
417MCall Options Held
7.19MPut Options Held
6.11M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.7 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.8 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.33 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.65 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.62 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $172B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...